Evidence map›Paper›PMID 29523243›Full record

ArticleMethods in enzymology2018

Assaying Repair at DNA Nicks.

Luther Davis, Yinbo Zhang, Nancy Maizels

Abstract read
In one paragraph

Article in Methods in enzymology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Article
  3. POLQ suppresses interhomolog recombination and loss of heterozygosity at targeted DNA breaks.Proceedings of the National Academy of Sciences of the United States of America · 2020
    Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Luther DavisUniversity of Washington, Seattle, WA, United States. Electronic address: lwd@uw.edu.
Yinbo ZhangUniversity of Washington, Seattle, WA, United States.
Nancy MaizelsUniversity of Washington, Seattle, WA, United States.
University of Washington · US

Funding

Tumor mutation signaturesP01CA077852 · NCI · UNIVERSITY OF WASHINGTON · PI SIDOROVA, JULIA · 1999 to 2019
$26.0M
Genomic Instability at DNA NicksR01CA183967 · NCI · UNIVERSITY OF WASHINGTON · PI MAIZELS, NANCY · 2014 to 2018
$1.6M
Mechanisms of loss of heterozygosity in cancerR21CA190675 · NCI · UNIVERSITY OF WASHINGTON · PI MAIZELS, NANCY · 2015 to 2016
$370k
NCI NIH HHS P01 CA077852NCI NIH HHS R01 CA183967NCI NIH HHS R21 CA190675
6 · The paper itself

Abstract

Nicks are the most common form of DNA damage, but they have only recently been shown to initiate damage that requires repair. Analysis of the pathways of nick repair in human cells has benefited from the development of enzymes that target nicks to specific sites in the genome and of reporters that enable rapid analysis of homology-directed repair and mutagenic end joining. Nicks undergo efficient repair by single-stranded oligonucleotide donors complementary to either the nicked or intact DNA strand, via pathways that are normally suppressed by RAD51. Here we discuss the details of reporter assays that take advantage of the convenience and sensitivity of flow cytometry to analyze pathways of repair at targeted DNA nicks. These assays are readily carried out in 96-well format cell culture plates, enabling mechanistic questions to be addressed by determining the contributions of specific factors by depletion and/or ectopic expression.

Indexed as

DNA BreaksDNA RepairDNADNA End-Joining RepairGenetic TechniquesHumansRecombinational DNA RepairDNACRISPR/CasGene therapyGenome engineeringHomology-directed repairMutagenesisRecombination

Identifiers

PMID29523243
PMCPMC6039113
OpenAlexW2792129593

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.